Automation Anywhere Licenses

The contract seeks to implement Automation Anywhere licenses to enhance the Food and Drug Administration’s use of risk analytics through automated workflows and advanced analytical tools. The goal is to improve decision-making in inspections, training, regulatory cooperation, and surveillance by enabling more effective aggregation and analysis of diverse data sources. This includes leveraging data mining techniques on intelligence-related information to uncover correlations, detect emerging trends, and perform statistical analyses that support comprehensive risk assessments. The approach aims to move beyond traditional methods by integrating threat intelligence directly into the allocation of inspection and testing resources, ensuring that limited resources are prioritized based on the most current and actionable risk insights. The contract is forecasted under NAICS code 541519 for other computer-related services and is issued by the FDA’s Center for Drug Evaluation and Research. Point of contact for program inquiries is cderacquisitions@fda.hhs.gov, with the contracting officer role pending assignment. The implementation will occur within the agency’s existing operational framework, focusing on enhancing analytical capacity without specifying a physical location for performance. The initiative emphasizes automation, intelligence-driven prioritization, and systemic integration of risk analytics to strengthen regulatory oversight and response efficiency.